Fission Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.25 M
- Company Age 5 Year, 4 Months
About Fission Pharmaceuticals
Fission Pharmaceuticals Private Limited (FPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2019 (Five years and four months 10 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Prakash Sanghai, Kshitij Daruka, and Sandeep Bansal serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304MH2019PTC330966
-
Company No.
330966
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Sep 2019
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Fission Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Sanghai
|
Director | 25-Sep-2019 | Current |
|
Kshitij Daruka
|
Director | 25-Sep-2019 | Current |
|
Sandeep Bansal
|
Director | 25-Sep-2019 | Current |
Financial Performance of Fission Pharmaceuticals.
Enhance accessibility to Fission Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fission Pharmaceuticals?
Unlock access to Fission Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
J. J. Iron And Steel Private LimitedPrakash Sanghai is a mutual person
-
Euro Agrotech India Private Limited
Kshitij Daruka is a mutual person
-
Aromatic Rasayan Private Limited
Sandeep Bansal is a mutual person
-
Ambey Laboratories Limited
Sandeep Bansal is a mutual person
-
Sg Reftech Private Limited
Sandeep Bansal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fission Pharmaceuticals?
Unlock and access historical data on people associated with Fission Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fission Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fission Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.